DoJ Copaxone Kickback Suit ‘Flawed’ And An ‘Overreach,’ Teva Says
Teva Has Filed Motion To Dismiss FCA Complaint
Executive Summary
Teva was accused by the US Department of Justice of violating anti-kickback law in donating money to charities that was later used to cover patient co-pays for Copaxone. In a rebuke aimed at having the suit dismissed, the Israeli manufacturer labelled the DoJ’s suit as “fatally flawed.”